News
Article
Author(s):
Catch up on coverage from the fourth day of the 2024 American Academy of Dermatology Annual Meeting.
To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.
Gallo presented pearls on the pathophysiology of acne and how newer studies have changed acne treatment methodologies.
Jenny Murase, MD, said the average dermatologist manages 2-3 patients with delusional infestations every 5 years. Learn what to expect and how to manage it with empathy.
Lio discussed his sessions at AAD, including addressing systemic malignancies with alternative or adjunctive therapies and the importance of minimizing pain in dermatology procedures.
Mona Shahriari, MD, presented real-world data on the efficacy of IL-23 inhibitors for psoriasis, as well as shared her advice from the Bristol Myers Squibb Women's Connection Forum.
The injectable polidocanol exhibited high efficacy, quicker onset of benefit, reduced downtime, and fewer side effects lasting longer than 30 days.
Waibel shared pearls in laser therapy and other scar treatment modalities in her talks at AAD.
Menes Kizoulis shared key highlights from the research conducted alongside leading dermatologists, like Alan Irvine, MD, DSc, and Patricia Farris, MD, MS.
Naiem Issa, MD, PhD, emphasized the importance of increased awareness regarding antibiotic stewardship among dermatologists, as well as the recently updated acne guidelines.
Furthermore, prenatal exposure to hyperandrogenism, a hormonal imbalance characteristic of HS, may influence the health outcomes of boys and girls differently.
A vote during the annual meeting will keep DEI initiatives in place and members are awaiting news on what those initiatives will look like.
Christopher Bunick, MD, PhD, presented updates and new data on the recent news of benzene found in benzoyl peroxide products.
The poster shares results form consensus research on using LODM for hair loss.